Hyperinsulinemia and insulin resistance
Diabetes is usually characterized by profound peripheral insulin resistance in PanCa patients. Schneider
et al. found that although half of the hamsters in their high-fat group developed malignant lesions with increased hyperplasia, the premalignant lesions were found within the islets. This finding may explain why the association between PanCa and obesity is usually associated with peripheral insulin resistance [
27].
The intracellular mechanism of insulin resistance in PanCa has been investigated. Liu
et al. found multiple defects in glycogen synthesis in PanCa patients with or without diabetes. Furthermore, the fractional velocity of glycogen synthase was decreased, whereas glycogen phosphorylase a and b activities were increased, in diabetic PanCa patients. However, glycogen phosphorylase mRNA levels were not significantly different, meaning that the insulin resistance associated with PanCa is associated with a post-insulin receptor defect, which impairs skeletal muscle glycogen synthesis and glycogen storage, leading to the hyperglycemia commonly observed in relation to PanCa [
28]. While investigating islet function and secretion during early development of PanCa, Permert
et al. found that plasma glucagon and islet amyloid polypeptide (IAPP) were significantly increased at 12 and 27 weeks, respectively, showing that islet hormone changes accompany the early development of pancreatic tumors in the hamster pancreatic cancer model [
29]. Krechler
et al. have studied the associations of the single nucleotide polymorphism -23HphI, which neighbors the variable number of tandem repeats locus in the upstream promoter of the insulin gene (INS), with PanCa and type 2 diabetes, and found that polymorphism of -23HphI (A/T) may play a role in the pathogenesis of PanCa and could contribute to tumor staging [
30].
Genotype and the progression of PanCa in diabetes
Dong
et al. hypothesized that genetic variants in glucose metabolism modify individual susceptibility to PanCa, especially those associated with diabetes, and retrospectively genotyped 26 single-nucleotide polymorphisms in five glucose metabolism genes. The
HK2 R844K GA/AA genotype was associated with a reduced risk of PanCa among nondiabetic individuals but with increased risk among diabetic patients. Their findings show a potential role of the
HK2 gene, alone or in combination with diabetes, in modifying the risk of PanCa [
34]. In a case–control study, Fryzek
et al. found that diabetes diagnosed five or more years prior was associated with pancreatic cancer that was positive for K-ras codon 12 mutations, but not meaningfully related to patients with p53 mutations, though further large-scale studies are warranted [
35].
Subsequent studies have identified a multitude of molecules, for which expression was altered in cancer cells, thus suggesting a potential role for these molecules in PanCa (Table
2).
Table 2
Molecular factors involved in progression in PanCa cells related to diabetes
IGF-1 and receptor | Increased | Increase the risk and worse survival | |
14-amino-acid peptide from S100A8 | Increased | Promote the growth of PanCa by activating Akt and NF-κB signaling | |
Regenerating gene I alpha protein | Increased | Accelerated cell proliferation | |
| Increased | Predictors of poor survival | |
| Increased | Contribute to determining diabetes | |
Insulin-like growth factor 1 (IGF-1) and IGF-1 receptor are highly expressed in pancreatic cancer cells [
36]. Suzuki
et al. showed that polymorphic variants of the IGF genes alone or in concert with diabetes increase the risk of PanCa [
37]. Thus, individual genetic variations in the IGF axis may predict worse survival in patients with PanCa [
38]. Basso
et al. isolated a 14-amino-acid peptide from S100A8 in PanCa tissue from diabetics and found that NT-S100A8 exerts a mild effect on PanCa cell growth in BxPC3, while it reduces PanCa cell invasion in MiaPaCa2 and Panc1, possibly by activating Akt and NF-κB signaling [
39,
40]. Furthermore, Zhou
et al. found that the regenerating gene (REG) I-alpha protein was preferentially expressed in cancerous tissues and cancer cells of PanCa patients with diabetes and that overexpression of this protein resulted in accelerated cell proliferation and consequently tumor growth, both
in vitro and
in vivo[
41]. A systemic inflammatory response is often observed in PanCa. For example, C-reactive protein was an independent predictor of survival [
42]. Furthermore, circulating levels of several cytokines were high in patients with pancreatic carcinoma. Interleukin 6, which is released in large amounts by the inflamed pancreas in PanCa, may contribute to diabetes [
43].
The association between diabetes and PanCa has long been recognized as that long-standing diabetes is thought to be an etiologic factor for PanCa and new-onset diabetes mellitus may be a manifestation of the cancer, both of which are characterized by hyperglycemia. The potential mechanisms of hyperglycemia in PanCa are shown in Table
3.
Table 3
The potential mechanisms of hyperglycemia in PanCa progression
RAGE | | Increased | Increased metastatic ability | |
ROS | Hydrogen peroxide | Increased | Enhanced the invasive and | |
| | Increased | migratory activity | |
Antioxidant | MnSOD | Decreased | Enhanced the invasive and migratory activity | |
enzymes | Catalase, glutathione peroxidase | Decreased | | |
| | Decreased | | |
Cytokines and their receptors | GDNF and RET | Increased | Enhanced cell proliferation | |
| EGF | Increased | Enhanced cell proliferation | |
| EGFR | Transactivation | Enhanced cell proliferation | |
| NGF | Increased | Aggravated the process of perineural invasion | |
| P75 | Decreased | | |
In a microarray analysis of myoblasts cultured in PanCa cell-conditioned media, Basso
et al. found that lactate production and induced proteolysis were enhanced in the myoblasts, which can induce hyperglycemia [
44]. Hyperglycemia and oxidative stress can lead to the accumulation of advanced glycation end products (AGEs). Studies have reported the strong expression of RAGE in MiaPaCa-2 and Panc-1 that have high metastatic ability [
45,
46]. Reactive oxygen species (ROS) appear to be linked to PanCa. ROS have also been suggested to be mitogenic and capable of stimulating cell proliferation. In diabetic individuals, hyperglycemia in susceptible cells results in the overproduction of superoxide by the mitochondrial electron transport chain, and this process is the key to initiating all damaging pathways related to diabetes [
47]. Hyperglycemia also specifically activates polyol metabolism with a consequent decrease in Na+, K + −ATPase activity in pancreatic duct epithelial cells [
48]. Moreover, hyperglycemia enhances the invasive and migratory activity of pancreatic cancer cells via hydrogen peroxide and the increased expression of urokinase plasminogen activator (uPA) [
49].
Hyperglycemia can attenuate antioxidant enzyme activity and in turn create a state of oxidative stress [
50]. The PanCa lines BxPC-3, MiaPaCa-2, and AsPC-1 have decreased manganese superoxide dismutase (MnSOD) immunoreactive protein expression and activity, and decreases in MnSOD correlate well with increased rates of tumor cell proliferation as determined by cell doubling time [
51]. Cullen
et al. found that the cytoplasmic values of MnSOD, catalase, and glutathione peroxidase were decreased in pancreatic cells from chronic pancreatitis specimens when compared with normal pancreas [
52]. Additionally, elevated fructose may directly contribute to oxidative stress in pancreatic cancer. Suzuki
et al. showed that fructose increases H2O2 levels and lipid peroxidation of hamster islet tumor cells, which originated from hamster pancreatic beta cells. Furthermore, glutathione peroxidase (GPx) is inactivated by fructose, and the mRNA expression of GPx is suppressed by fructose [
53].
Glial cell line-derived neurotrophic factor (GDNF) is a chemoattractant for pancreatic cancer cells in the processes of tumor progression, migration and invasion. In
in vitro studies, Jemal
et al. have confirmed the stimulating effect of GDNF on the proliferation and invasion of pancreatic cancer cells through the activation of the RET tyrosine kinase receptor [
54,
55]. Glucose alters the expression of GDNF and RET in a concentration-dependent manner, corresponding with the alterations in cell proliferation. Upregulation of the GDNF and RET ligand-receptor interaction might participate in the glucose-induced cancer progression [
56]. High glucose also promotes PanCa cell proliferation via the induction of epidermal growth factor (EGF) expression and transactivation of EGFR [
57].
The role of hyperglycemia in perineural invasion in pancreatic cancer is not clear. We have hypothesized that hyperglycemia promotes perineural invasion in PanCa by effects on nerve and cancer cells, respectively [
58]. Our clinical study also showed that nerve damage and regeneration occur simultaneously in the tumor microenvironment of PanCa patients with hyperglycemia, thereby aggravating the process of perineural invasion. The abnormal expression of nerve growth factor (NGF) and p75 may also be involved in this process and subsequently lead to a lower rate of curative surgery [
59].